Role of tubular cells in progressive renal disease

Kidney and Blood Pressure Research

Volumn 22, Issue 1-2, 1999, Pages 53-61

  Van Kooten, Cees ^a   Langers, Alexandra M J ^a   Bruijn, Jan A ^a   Daha, Mohamed R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CD40; Chemokines; Cytokines; Fibrosis; Inflammation; Kidney; Matrix components; Tubular epithelial cells

Indexed keywords

CD40 ANTIGEN; CHEMOKINE; COMPLEMENT; CYTOKINE;

ARTICLE; CELL ACTIVATION; CELL CULTURE; EPITHELIUM CELL; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY TUBULE CELL; KIDNEY TUBULE DAMAGE; KIDNEY TUBULE EPITHELIUM; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD40; DISEASE PROGRESSION; EPITHELIAL CELLS; HUMANS; KIDNEY DISEASES; KIDNEY TUBULES;

EID: 0032978527     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000025909     Document Type: Article

References (76)

1. Klahr S, Schreiner G, Ichikawa I: The progression of renal disease. N Engl J Med 1988;318: 1657-1666.
2. Nath KA: Tuhulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992;20:1-17.
3. Remuzzi G, Ruggeneti P, Benigni A: Understanding the nature of renal disease progression. Kidney Int 1997;51:2-15.
4. Okada H, Strutz F, Danoff TM, Neilson EG: Possible pathogenesis of renal fibrosis. Kidney Int 1996;49:s37-38.
5. Terzi F, Burtin M, Friedlander G: Early molecular mechanisms in the progression of renal failure: Role of growth factors and protooncogenes. Kidney Int 1998;53(suppl 65):S68-S73.
6. Philips AO, Steadman R, Morrisey K, Williams JD: Polarity of stimulation and secretion of transforming growth factor-β-1 by cultured proximal tubular cells. Am J Pathol 1997;150:1101-1111.
7. Van der Biest I, Nouwen EJ, Van Dromme SA, De Broe ME: Characterization of pure proximal and heterogeneous distal human tubular cells in culture. Kidney Int 1994;45:85-94.
8. Helbert MJ, Dauwe SE, Van der Biest I, Nouwen EJ, De Broe ME: Immunodissection of the human proximal nephron: flow sorting of S1S2S3, SIS2 and S3 proximal tubular cells. Kidney Int 1997;52:414-428.
9. Baer PC, Nockher WA, Haase W, Scherberich JE: Isolation of proximal and distal tubule cells from human kidney by immunomagnetic separation. Kidney Int 1997;52:1321-1331.
10. Seelen MA, Brooimans RA, van der Woude FJ, van Es LA, Daha MR: IFN-gamma mediates stimulation of complement C4 biosynthesis in human proximal tubular epithelial cells. Kidney Int 1993;44:50-57.
11. Gerritsma JSJ, Gerritsen AF, De Ley M, Van Es LA, Daha MR: Interferon-gamma induces biosynthesis of complement components C2, C4 and factor H by human proximal tubular epithelial cells. Cytokine 1997;9:276-283.
12. Gerritsma JSJ, Gerritsen AF, Van Kooten C, Van Es LA, Daha MR: Expression of the IL-2 receptor on human renal proximal tubular epithelial cells. J Am Soc Nephrol 1997;8:1510-1516.
13. Gerritsma JSJ, Gerritsen AF, Van Kooten C, Van Es LA, Daha MR: Interleukin-1-alpha enhances the biosynthesis of complement C3 and factor B by human kidney proximal tubular epithelial cells in vitro. Molec Immunol 1996;33: 847-854.
14. Van Kooten C, Boonstra JG, Paape ME, Fossiez F, Banchereau J, Lebecque S, Bruijn JA, De Fijter JW, Van Es LA, Daha MR: Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection. J Am Soc Nephrol 1998;9:1526-1534.
15. Brooimans RA, Stegman APA, van Dorp WT, van der Woude FJ, van Es LA, Daha MR: Interleukin 2 mediates stimulation of complement C3 by human proximal tubular epithelial cells (PTEC). J Clin Invest 1991;88:379-384.
16. Gerritsma JSJ, Van Kooten C, Gerritsen AF, Van Es LA, Daha MR: TGF-β1 regulates chemokine and complement production by human proximal tubular epithelial cells. Kidney Int 1998;53:609-616.
17. Jevnikar AM, Brennan DC, Singer GG, Heng JE, Maslinski W, Wuthrich RP, Glimcher LH, Rubin Kelley VE: Stimulated kidney tubular epithelial cells express membrane associated and secreted TNF alpha. Kidney Int 1991;40: 203-211.
18. Yard BA, Daha MR, Kooymans-Couthino M, Bruijn JA, Paape ME, Schrama E, van Es LA, van der Woude FJ: IL-1 alpha stimulated TNF alpha production by cultured human proximal tubular epithelial cells. Kidney Int 1992;42: 383-389.
19. von Asmuth EJU, Dentener MA, Ceska M, Buurman WA: IL6, IL8 and TNF production by cytokine and lipopolysaccharide-stimulated human renal cortical epithelial cells in vitro. Eur Cytokine Netw 1994;5:301-310.
20. Boswell RN, Yard BA, Schrama E, van Es LA, Daha MR, van der Woude FJ: Interleukin 6 production by human proximal tubular epithelial cells in vitro: Analysis of the effects of interleukin-1 alpha (IL-1 alpha) and other cytokines. Nephrol Dial Transplant 1994;9:599-606.
21. Schmouder RL, Stricter RM, Wiggins RC, Chensue SW, Kunkel SL: In vitro and in vivo interleukin-8 production in human renal cortical epithelia. Kidney Int 1992;41:191-198.
22. Weiler M, Rogashev B, Einbinder T, Hausmann MJ, Kaneti J, Chaimovitz C, Douvdevani A: Interleukin-15, a leukocyte activator and growth factor, is produced by cortical tubular epithelial cells. J Am Soc Nephrol 1998;9:1194-1201.
23. Baggiolini M: Chemokines and leukocyte traffic. Nature 1998;392:565-568.
24. Schlondorf D, Nelson PJ, Luckow B, Banas B: Chemokines and renal disease. Kidney Int 1997;51:610-621.
25. Nadeau KC, Azuma H, Tilney NL: Sequential cytokine dynamics in chronic rejection of rat renal allografts: Roles for cytokines RANTES and MCP-1. Proc Natl Acad Sci USA 1995; 92:8729-8733.
26. Lloyd CM, Minto AW, Dorf ME, Proudfoot A, Wells TNC, Salant DJ, Gutierrez-Ramos JC: RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med 1997;185: 1371-1380.
27. Gerritsma JSJ, Hiemstra PS, Gerritsen AF, Prodjosudjadi W, Verweij CL, Van Es LA, Daha MR: Regulation and production of IL-8 by human proximal tubular epithelial cells in vitro. Clin Exp Immunol 1996;103:289-294.
28. Schmouder RL, Strieter RM, Kunkel SL: Interferon-gamma regulation of human renal cortical epithelial cell-derived monocyte chemotactic peptide-1. Kidney Int 1993;44: 43-49.
29. Schmouder RL, Streiter RM, Walz A, Kunkel SL: Epithelial-derived neutrophil-activating factor-78 production in human renal tubule epithelial cells and in renal allograft rejection. Transplantation 1995;59:118-124.
30. Prodjosudjadi W, Gerritsma JSJ, Klar-Mohamed N, Gerritsen AF, Bruijn JA, Daha RD, van Es LA: Production and cytokine-mediated regulation of monocyte chemoattractant protein-1 by proximal tubular epithelial cells. Kidney Int 1995;48:1477-1486.
31. Yokoyama H, Wada T, Furuichi K, Segawa C, Shimizu M, Kobayashi K, Su S, Mukaida N, Matsushima K: Urinary levels of chemokines (MCAF/MCP-1, IL-8) reflect distinct disease activities and phases of human IgA nephropathy. J Leuk Biol 1998;63:493-499.
32. Prodjosudjadi W, Daha MR, Gerritsma JSJ, Florijn KW, Barendrecht JNM, Bruijn JA, Van der Woude FJ, Van Es LA: Increased urinary excretion of monocyte chemoattractant protein-1 during acute renal allograft rejection. Nephrol Dial Transplant 1996;11:1096-1103.
33. Heeger P, Wolf G, Meyers C, Sun MJ, O'Farrel SC, Krensky AM, Neilson EG: Isolation and characterization of cDNA from renal tubular epithelium encoding murine RANTES. Kidney Int 1992;41:220-225.
34. Deckers JGM, Van der Woude FJ, Van der Kooij SW, Daha MR: Synergistic effect of IL-1α, IFN-γ and TNF-α on RANTES production by human renal tubular epithelial cells in vitro. J Am Soc Nephrol 1998;9:194-202.
35. Pattison J, Nelson PJ, Huie P, Von Leutticha I, Farshid G, Sibley RK, Krensky AM: RANTES chemokine expression in cell-mediated transplant rejection of the kidney. Lancet 1994;343: 209-211.
36. Deckers JGM, De Haij S, Van der Woude FJ, Van der Kooij SW, Daha MR, Van Kooten C: IL-4 and IL-13 augment cytokine- and CD40-induced RANTES production by human renal tubular epithelial cells in vitro. J Am Soc Nephrol 1998;9:1187-1193.
37. Stephens ND, Barton SL, Smith AY, Paul RW, Neidhardt JA, Griffith JK: GM-CSF secretion in primary cultures of normal and cancerous human renal cells. Kidney Int 1996;50:1044-1050.
38. Fan X, Oertli B, Wuthrich RP: Up-regulation of tubular epithelial interleukin-12 in autoimmune MRL-Fas lpr mice with renal injury. Kidney Int 1997;51:79-86.
39. Pichler R, Giachelli CM, Lombardi D, Pippin J, Gordon K, Alpers CE, Schwartz SM, Johnson RJ: Tubulointerstitial disease in glomerulonephritis: Potential role of osteopontin (uropontin). Am J Pathol 1994;144:915-926.
40. Frank J, Engler-Blum G, Rodeman HP, Muller GA: Human renal tubular cells as a cytokine source: PDGF-B, GM-CSF and IL-6 mRNA expression in vitro. Exp Nephrol 1993;1:26-35.
41. Homma T, Sakai M, Cheng HF, Yasuda T, Coffey RJ, Harris RC: Induction of heparin-binding epidermal growth factor-like growth factor mRNA in rat kidney after acute injury. J Clin Invest 1995;96:1018-1025.
42. Philips AO, Steadman R, Topley N, Williams JD: Eleva:ed D-glucose concentrations modulate TGF-beta-1 synthesis by human cultured renal proximal tubular epithelial cells. Am J Pathol 1995;147:362-374.
43. Philips AO, Topley N, Morrisey K, Williams JD, Steadman R: Basic fibroblast growth factor stimulates the release of preformed transforming growth factor β1 from human proximal tubular cells in the absence of de novo gene transcription or mRNA translation. Lab Invest 1997;76:591-600.
44. Vleming LJ, Baelde JJ, Westendorp RGJ, Daha MR, Van Es LA, Bruijn JA: Progression of chronic renal disease in humans is associated with the deposition of basement membrane components and decorin in the interstitial extracellular matrix. Clin Nephol 1995;44:211-219.
45. Vleming LJ, Baelde HJ, Westendorp RGJ, Daha MR, Van Es LA, Bruijn JA: The glomerular deposition of PAS positive material correlates with renal function in human kidney diseases. Clin Nephrol 1997;47:158-167.
46. Schafer K, Boder M, Gratz N, Oberbaumer I: Focal overexpression of collagen IV characterizes the initiation of epithelial changes in polycystic kidney disease. Exp Nephrol 1994;2: 190-195.
47. Bergijk EC, Baelde JJ, De Heer E, Killen PD, Bruijn JA: Role of the extracellular matrix in the development of glomerulosclerosis in experimental chronic serum sickness. Exp Nephrol 1995;3:338-347.
48. Scheinman JI, Tanaka H, Haralson M, Wang SL, Brown O: Specialized collagen mRNA and secreted collagens in human glomerular epithelial, mesangial and tubular cells. J Am Soc Nephrol 1992;2:1475-1483.
49. Humes DH, Nakamura T, Cieslinski DA, Miller D, Emmons R, Border WA: Role of proteoglycans and cytoskelaton in the effects of TGF-β1 on renal proximal tubule cells. Kidney Int 1993;43:575-584.
50. Wolf G, Zahner G, Schroeder R, Stahl RAK: Transforming growth factor beta mediates the angiotensin-II-induced stimulation of collagen type IV synthesis in cultured murine proximal tubular cells. Nephrol Dial Transplant 1996; 11:263-269.
51. Burton CJ, Combe C, Walls J, Harris KPG: Fibronectin production by human tubular cells: The effect of apical protein. Kidney Int 1996; 50:760-767.
52. Viedt C, Burger A, Hansch GM: Fibronectin synthesis in tubular epithelial cells: Up-regulation of the EDA splice variant by transforming growth factor β. Kidney Int 1995;48:1810-1817.
53. Eddy AA: Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. J Am Soc Nephrol 1994; 5:1273-1287.
54. Abbate M, Zoja C, Corna D, Capitanio M, Bertani T, Remuzzi G: In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation. J Am Soc Nephrol 1998;9:1213-1224.
55. Remuzzi G: Abnormal protein traffic through the glomerular barrier induces proximal tubular dysfunction and causes renal injury. Curr Opin Nephrol Hyperten 1995;4:339-342.
56. Wang Y, Chen J, Chen L, Tay YC, Rangan KR, Hams DCH: Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. J Am Soc Nephrol 1997;8: 1537-1545.
57. Zoja C, Donadelli R, Colleoni S, Figliuzzi M, Bonazzola S, Morigi M, Remuzzi G: Protein overload stimulates RANTES production by proximal tubular cells depending on NF-(greek kappa symbol)B activation. Kidney Int 1998;53:1608-1615.
58. Zoja C, Morigi M, Figliuzzi M, Bruzzi I, Oldroyd S, Benigni A, Ronco PM, Remuzzi G: Proximal tubular cell synthesis and secretion of endothelin-1 on challange with albumin and other proteins. Am J Kidney Dis 1995;26:934-941.
59. Kees-Folts D, Sadow J, Schreiner GF: Tubular catabolism of albumin is associated with the release of an inflammatory lipid. Kidney Int 1994;45:1697-1709.
60. Orphanides C, Fine LG, Norman JT: Hypoxia stimulates proximal tubular cell matrix production via a TGF-β1-independent mechanism. Kidney Int 1997;52:637-647.
61. Peruzzi E, Trusolino L, Amore A, Gianoglio B, Cirina P, Basso G, Emancipator SN, Marchisio PC, Coppo R: Tubulointerstitial responses in the progression of glomerular diseases: Albuminuria modulates αvβ5 integrin. Kidney Int 1996;50:1310-1320.
62. Combe C, Burton CJ, Dufourcq P, Weston S, Horsburgh T, Walls J, Harris KPG: Hypoxia induces intercellular adhesion molecule-1 on cultured human tubular cells. Kidney Int 1997; 51:1703-1709.
63. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, Van Kooten C, Liu YJ, Rousset F, Saeland S: The CD40 antigen and its ligand. Annu Rev Immunol 1994;12:881-922.
64. Van Kooten C, Banchereau J: CD40-CD40 ligand: A multifunctional receptor-ligand pair. Adv Immunol 1996;61:1-77.
65. Van Koolen C, Banchereau J: Function of CD40 on B cells, dendritic cells and other cells. Curr Opin Immunol 1997;9:330-337.
66. Yellin MJ, D'Agati V, Parkinson G, Han ASY, Szema A, Baum D, Estes D, Szabolzs M, Chess L: Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides. Arthritis Rheum 1997;40:124-134.
67. Van Kooten C, Gerritsma JSJ, Paape ME, Van Es LA, Banchereau J, Daha MR: Possible role for CD40-CD40L in the regulation of interstitial infiltration in the kidney. Kidney Int 1997;51:711-721.
68. Kluth B, Hess S, Engelmann H, Schafnitzel S, Tiethmuller G, Feucht HE: Endothelial expression of CD40 in renal cell carcinoma. Cancer Res 1997;57:891-899.
69. Graf D, Muller S, Korthauer U, van Kooten C, Weise C, Kroczek RA: A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation. Eur J Immunol 1995;25: 1749-1754.
70. Pietravalle F, Lecoanet-Henchoz S, Blasey H, Aubry JP, Elson G, Edgerton MD, Bonnefoy JY, Gauchat JF: Human native soluble CD40L is a biologically active trimer, processed inside microsomes. J Biol Chem 1996;271:5965-5967.
71. Larsen CP, Pearson TC: The CD40 pathway in allograft rejection, acceptance, and tolerance. Curr Opin Immunol 1997;9:641-647.
72. Durie FH, Fava RA, Foy TM, Aruffb A, Ledbetter JA, Noelle RJ: Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 1993;261:1328-1330.
73. Kalled SE, Cutler AH, Datta SK, Thomas DW: Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: Preservation of kidney function. J Immunol 1998;160: 2158-2165.
74. Lei X, Ohkawara Y, Stampfli MR, Mastruzzo C, Marr RA, Snider D, Xing Z: Disruption of antigen-induced inflammatory responses in CD40 ligand knockout mice. J Clin Invest 1998;101:1342-1353.
75. Adawi A, Zhang Y, Baggs R, Finkelstein J, Phipps RP: Disruption of the CD40-CD40 ligand system prevents an oxygen-induced respiratory distress syndrome. Am J Pathol 1998; 152:651-657.
76. Mach F, Schonbeck U, Sukhova GK, Atkinson E, Libby P: Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 1998;394:200-203.